This was the stock's second consecutive day of gains.

Raymond James resumed coverage of Regenxbio (RGNX) with an Outperform rating and $27 price target The firm expects the launch of Elevidys and ...

January finished with an earthquake in the tech world, when the Chinese startup DeepSeek released its new AI assistant – and ...

Raymond James Financial, a leading financial services company, has announced its robust first-quarter performance for Fiscal ...

Symbotic (NASDAQ:SYM) shares fell more than 17% in Thursday trade after Raymond James downgraded its rating from Outperform to Market Perform following a disappointing first quarter results. The ...